Scoring procedure.

<p>Scoring procedure.</p

Distribution of scores per group and phase.

<p>Distribution of scores per group and phase.</p

Descriptive data.

<p>Mean, (standard deviation)</p><p>* <i>for the ASD group</i>, <i>n = 14 (10 boys; 4 girls)</i></p><p>Descriptive data.</p

Distribution of scores for gaze per group and phase.

<p>Distribution of scores for gaze per group and phase.</p

Sensor-space coherence levels at 0.5 Hz.

<p>*<i>p</i>>0.05.</p><p>Live and Recorded: sensor-space coherence levels obtained in ASD patients.</p><p>Controls: sensor-space coherence levels obtained in Exp1m in the seminal CVC study (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0092329#pone-0092329-t001" target="_blank">Table 1</a>, Bourguignon et al. 2013).</p

Individual coherence spectra in ASD subjects.

<p>Individual coherence spectra obtained in each condition for the right-hemisphere MEG sensor showing the maximum coherence level. Significant coherence at 0.5 Hz was observed in all ASD subjects in <i>Live</i> and in 6 out of 7 subjects in <i>Recorded</i>. Y–axis values are identical on both plots.</p

Patients' clinical details.

<p>(M: male; F: female; AD: autistic disorder; ASD: Asperger syndrome; SD: standard deviation; TLOCC: test de langage oral complexe pour collégiens; ADOS: autism diagnostic observation schedule; C: communication; SI: social interaction;</p><p>*: speech abnormalities associated with autism, coded item 2 of the ADOS Language and Communication domain).</p

Group-level coherence maps in ASD subjects.

<p>Group level coherence maps computed at 0.5(<i>Live</i>, red; <i>Recorded</i>, green; intersection between <i>Live</i> and <i>Recorded</i>, yellow). In <i>Live</i>, the maximum coherence occured at the right superior temporal sulcus and in <i>Recorded</i>, at the upper bank of the middle temporal gyrus. Coherence maps were thresholded at the maximum of coherence to isolate the local coherence maxima (<i>Live</i>, coherence threshold: 0.64–0.71; <i>Recorded</i>, coherence threshold: 0.60–0.67).</p

Additional file 2: of Novel promoters and coding first exons in DLG2 linked to developmental disorders and intellectual disability

Knowledge-driven analysis results. (XLSX 13 kb

Correlation between MyoSets at baseline on dominant (D) and non-dominant (ND) sides, clinical and motor function parameters.

<p>* p-value < 0.05,</p><p>** p-value < 0.01.</p><p>Correlation between MyoSets at baseline on dominant (D) and non-dominant (ND) sides, clinical and motor function parameters.</p